Core Laboratories Inc.
DE ˙ DB ˙ US21867A1051
11,00 € ↓ -0,50 (-4,35%)
2026-06-05
AKTIENPREIS
SecurityDE:HJ1 / Core Laboratories Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership10,268 shares
Latest Disclosed Value $ 172,400
Franklin Resources Inc reports 6.13% decrease in ownership of HJ1 / Core Laboratories Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 10,268 shares of Core Laboratories Inc. (DE:HJ1) valued at $147,859 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 10,938 shares of Core Laboratories Inc.. This represents a change in shares of -6.13% during the quarter. The current value of the position is $112,948 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F CORE LABORATORIES COM 21867A105 10,268 -670 -6.13 172 -1.71 0.0000
2026-02-11 2025-12-31 13F CORE LABORATORIES COM 21867A105 10,938 -8,433 -43.53 175 -26.78 0.0000
2025-11-13 2025-09-30 13F CORE LABORATORIES COM 21867A105 19,371 -4,397 -18.50 239 -12.45 0.0001
2025-08-12 2025-06-30 13F CORE LABORATORIES COM 21867A105 23,768 -3,791 -13.76 274 -33.90 0.0001
2025-05-13 2025-03-31 13F CORE LABORATORIES COM 21867A105 27,559 782 2.92 413 -10.80 0.0001
2025-02-12 2024-12-31 13F CORE LABORATORIES COM 21867A105 26,777 26,777 464 0.0001
2020-03-11 2019-12-31 13F/A-1 CORE LABORATORIES N V COM N22717107 0 -1,165,690 -100.00 0 -100.00
2019-11-14 2019-09-30 13F CORE LABORATORIES N V COM N22717107 1,165,690 18,470 1.61 54,344 -9.39 0.0295
2019-08-14 2019-06-30 13F CORE LABORATORIES N V COM N22717107 1,147,220 320,165 38.71 59,977 5.21 0.0319
2019-05-15 2019-03-31 13F/A-1 CORE LABORATORIES N V COM N22717107 827,055 87,215 11.79 57,009 29.16 0.0305
2019-05-14 2019-03-31 13F CORE LABORATORIES N V COM N22717107 827,055 87,215 57,009
2019-02-12 2018-12-31 13F CORE LABORATORIES N V COM N22717107 739,840 268,240 56.88 44,138 -19.20 0.0266
2018-11-13 2018-09-30 13F CORE LABORATORIES N V COM N22717107 471,600 10,600 2.30 54,626 -6.11 0.0272
2018-08-14 2018-06-30 13F CORE LABORATORIES N V COM N22717107 461,000 -9,800 -2.08 58,183 14.13 0.0298
2018-05-10 2018-03-31 13F CORE LABORATORIES N V COM N22717107 470,800 -19,466 -3.97 50,978 -5.08 0.0258
2018-02-14 2017-12-31 13F CORE LABORATORIES N V COM N22717107 490,266 12,866 2.70 53,708 13.98 0.0258
2017-11-13 2017-09-30 13F CORE LABORATORIES N V COM N22717107 477,400 116,300 32.21 47,119 28.85 0.0231
2017-08-10 2017-06-30 13F CORE LABORATORIES N V COM N22717107 361,100 -73,105 -16.84 36,568 -27.10 0.0182
2017-05-12 2017-03-31 13F CORE LABORATORIES N V COM N22717107 434,205 -197,400 -31.25 50,160 -33.84 0.0255
2017-02-14 2016-12-31 13F CORE LABORATORIES N V COM N22717107 631,605 51,600 8.90 75,818 16.37 0.0393
2016-11-14 2016-09-30 13F CORE LABORATORIES N V COM N22717107 580,005 7,500 1.31 65,152 -8.14 0.0341
2016-08-11 2016-06-30 13F CORE LABORATORIES N V COM N22717107 572,505 -27,595 -4.60 70,927 5.14 0.0382
2016-05-10 2016-03-31 13F CORE LABORATORIES N V COM N22717107 600,100 1,600 0.27 67,457 3.65 0.0358
2016-04-27 2015-12-31 13F/A-1 CORE LABORATORIES N V COM N22717107 598,500 28,800 5.06 65,080 14.46 0.0329
2016-02-12 2015-12-31 13F CORE LABORATORIES N V COM N22717107 598,500 65,080
2015-11-10 2015-09-30 13F CORE LABORATORIES N V COM N22717107 569,700 58,100 11.36 56,856 -2.55 0.0281
2015-08-12 2015-06-30 13F CORE LABORATORIES N V COM N22717107 511,600 511,600 0.00 58,342 0.0265
2015-02-10 2014-12-31 13F CORE LABORATORIES N V COM N22717107 0 -50,000 -100.00 0 -100.00
2014-11-12 2014-09-30 13F CORE LABORATORIES N V COM N22717107 50,000 -25,000 -33.33 7,318 -41.60 0.0033
2014-08-12 2014-06-30 13F CORE LABORATORIES N V COM N22717107 75,000 4,900 6.99 12,530 -9.93 0.0055
2014-05-13 2014-03-31 13F CORE LABORATORIES N V COM N22717107 70,100 20,000 39.92 13,911 45.41 0.0066
2014-02-12 2013-12-31 13F CORE LABORATORIES N V COM N22717107 50,100 0 0.00 9,567 12.85 0.0047
2013-11-14 2013-09-30 13F CORE LABORATORIES N V COM N22717107 50,100 100 0.20 8,478 11.80 0.0045
2013-08-09 2013-06-30 13F CORE LABORATORIES N V COM N22717107 50,000 50,000 7,583 0.0043
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.